<DOC>
	<DOCNO>NCT01277510</DOCNO>
	<brief_summary>The purpose study assess safety efficacy add cinacalcet current treatment secondary hyperparathyroidism child currently receive dialysis compare treatment regimen include cinacalcet .</brief_summary>
	<brief_title>Pediatric Chronic Kidney Disease Safety Efficacy</brief_title>
	<detailed_description>Secondary hyperparathyroidism ( SHPT ) condition develop early patient chronic kidney disease ( CKD ) , usually get bad time , know cause problem patient dialysis . Children dialysis wide range bone growth issue , common treatment chance make thing bad increase serum calcium serum phosphorus . Cinacalcet show effective control parathyroid hormone ( PTH ) , calcium phosphorus adult . The purpose study show include cinacalcet treatment SHPT low level intact parathyroid hormone ( iPTH ) large number pediatric patient CKD receive dialysis , compare treatment regimen include cinacalcet .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Hyperparathyroidism , Secondary</mesh_term>
	<mesh_term>Cinacalcet Hydrochloride</mesh_term>
	<criteria>Age 6 less 18 year screen Diagnosed CKD SHPT receive hemodialysis peritoneal dialysis ≥ 2 month randomization Dry weight ≥ 12.5 kg screen iPTH obtain central laboratory must &gt; 300 pg/mL ( 31.8 pmol/L ) Serum calcium ( correct ) obtain central laboratory must ≥ 8.8 mg/dL ( 2.2 mmol/L ) Serum phosphorus obtain central laboratory ≥ 4.0 mg/dL ( 1.3 mmol/L ) child 6 less 12 year old , ≥ 3.5 mg/dL ( 1.1 mmol/L ) child 12 less 18 year old Subjects already receive vitamin D sterols ( either calcitriol synthetic analog ) , stable dose within last 2 month prior randomization Subjects take growth hormone , stable dose define change &gt; 20 % last 2 month prior randomization Subjects anticonvulsant medication must stable dose 3 month , therapeutic blood level anticonvulsant time randomization Subjects must dialysate calcium concentration ≥ 2.5 mEq/L ( 1.25 mmol/L ) least 2 month prior randomization Underwent parathyroidectomy last 6 month Anticipated parathyroidectomy within 6 month randomization Received therapy cinacalcet ( sensipar/mimpara ) within last month A new onset seizure worsen preexisting seizure disorder within last 3 month Scheduled date kidney transplant know living donor make completion study unlikely</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>dialysis</keyword>
	<keyword>sensipar</keyword>
	<keyword>mimpara</keyword>
	<keyword>hemodialysis</keyword>
	<keyword>peritoneal dialysis</keyword>
	<keyword>renal</keyword>
	<keyword>parathyroid hormone</keyword>
	<keyword>pediatric</keyword>
</DOC>